Q1 2019 Sartorius AG Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Sartorius and Sartorius Stedim Biotech conference call on the Q1 results 2019. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Yes. Thank you, and welcome, everybody, to our Q1 call 2019. As always, we would like to first walk you through the results for the Sartorius Group for the first quarter of 2019, and then after that, we would like to walk you through the results for Sartorius Stedim Biotech, and then we will have time for questions and answers as well.
However, before I hand over to our CFO, Rainer Lehmann, to walk you through the figures in some more detail, I would just like to highlight maybe the key aspects of our results. First of all, we, I think, are really off to or into for a good start into 2019 with strong double-digit growth for both order intake as well as sales and even overproportionate double
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |